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Summary
Mammals possess multiple insulin-like growth factor
(IGF) binding proteins (IGFBPs), and related proteins,
that modulate the activity of insulin⁄IGF signalling (IIS),
a conserved neuroendocrine signalling pathway that
affects animal lifespan. Here, we examine if increased
levels of an IGFBP-like protein can extend lifespan, using
Drosophila as the model organism. We demonstrate
that Imaginal morphogenesis protein-Late 2 (IMP-L2), a
secreted protein and the ﬂy homologue of the human
IGFBP7 tumour suppressor, is capable of binding at least
two of the seven Drosophila insulin-like peptides
(DILPs), namely native DILP2 and DILP5 as present in the
adult ﬂy. Increased expression of Imp-L2 results in
phenotypic changes in the adult consistent with down-
regulation of IIS, including accumulation of eIF-4E
binding protein mRNA, increase in storage lipids,
reduced fecundity and enhanced oxidative stress resis-
tance. Increased Imp-L2 results in up-regulation of dilp2,
dilp3 and dilp5 mRNA, revealing a feedback circuit that
is mediated via the ﬂy gut and⁄or fat body. Importantly,
over-expression of Imp-L2, ubiquitous or restricted to
DILP-producing cells or gut and fat body, extends life-
span. This enhanced longevity can also be observed
upon adult-onset induction of Imp-L2, indicating it is not
attributable to developmental changes. Our ﬁndings
point to the possibility that an IGFBP or a related pro-
tein, such as IGFBP7, plays a role in mammalian aging.
Key words: aging; Drosophila; IMP-L2; insulin⁄insulin-
like growth factor signalling; insulin-like growth factor-
binding protein.
Introduction
The insulin⁄insulin-like growth factor (IGF) signalling (IIS) path-
way is an evolutionarily conserved neuroendocrine signalling
pathway that controls a variety of processes and traits in ani-
mals, including growth and development, energy metabolism,
reproduction and stress resistance. Genetic manipulations of
pathway components that result in dampened IIS extend life-
span in worms, ﬂies and mice, and ameliorate age-dependent
functional decline (Tatar et al., 2003; Piper et al., 2008). Genetic
variation in several components of this pathway is strongly asso-
ciated with human longevity (Kuningas et al., 2007; Willcox
et al., 2008; Flachsbart et al., 2009; Pawlikowska et al., 2009),
conﬁrming the relevance of IIS to human aging.
Central to the pathway are insulin-like ligands, which include
insulin, IGF-I and IGF-II in mammals (White, 2006); 38 insulin-like
peptides in worms (Pierce et al., 2001) and the seven Drosophila
insulin-like peptide (DILPs) in ﬂies (Brogiolo et al., 2001). The
ligands mediate cell-to-cell signalling by activating an insulin
receptor-like receptor, leading to the activation of PI3-kinase –
Akt, TOR and ERK intracellular signalling pathways (Tatar et al.,
2003; White, 2006; Piper et al., 2008). Importantly, not all
manipulations of the pathway result in lifespan extension (Clan-
cy et al., 2001; Tatar et al., 2001; Hwangbo et al., 2004; Sel-
man et al., 2008; Ikeya et al., 2009), suggesting that the
pathway needs to be manipulated to a speciﬁc level of signal
reduction and in speciﬁc tissues to achieve enhanced longevity.
In mammals, a layer of complexity is added to IIS by the pres-
ence of IGF binding proteins (IGFBPs). Six classic IGFBPs bind
IGF-I and IGF-II with high afﬁnity and act as modulators of IGF
activity. They can both enhance and dampen IIS by prolonging
the half-life of IGFs, altering their local and systemic availability
and preventing them from binding to the receptor (Hwa et al.,
1999). Furthermore, mammals possess IGFBP-related proteins,
such as IGFBP7, that bind IGFs with lower afﬁnity (Hwa et al.,
1999). Notably, IGFBP7 has received attention as a potent
secreted tumour suppressor acting in an autocrine⁄paracrine
manner to block melanoma genesis (Wajapeyee et al., 2008).
Insects also possess IGFBP-like proteins, the ﬁrst of which was
discovered serendipitously, allowing the subsequent identiﬁca-
tion of the Drosophila Imaginal morphogenesis protein-Late 2
(Imp-L2) (Sloth Andersen et al., 2000; Alic & Partridge, 2008).
IMP-L2 resembles IGFBP7 in sequence and it appears to be
equivalent to an IGFBP in function, acting as a negative regulator
of IIS during development, regulating growth cell-non-autono-
mously and antagonising dilp2 in genetic assays (Honegger
et al., 2008). Interestingly, when the germline is ablated late in
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lﬂy development, lifespan is increased with a concomitant
increase in the levels of Imp-L2 mRNA (Flatt et al., 2008), indi-
cating that one of the roles of Imp-L2 may be to mediate a life-
span-extending signal emanating from the gonad to IIS in the
soma. However, the role of this gene in IIS in the adult ﬂy,
including its capacity to enhance longevity, has not been
examined.
While the complex and important effects of IGFBPs on IIS in
mammals and, in turn, the role of IIS in animal lifespan are both
well established, no study has examined if IGFBPs or related pro-
teins can alter animal physiology in such a way as to enhance
longevity. To determine if increased function of an IGFBP can
extend lifespan, we used Drosophila as a model; such an
approach has been fruitful in the past, when the ﬁnding that a
mutation in an insulin-receptor substrate extends lifespan in the
ﬂy (Clancy et al., 2001) was subsequently conﬁrmed in mam-
mals (Taguchi et al., 2007; Selman et al., 2008). Here, we show
that the ﬂy IGFBP homologue, IMP-L2, binds native DILP2 and
DILP5, is involved in a feedback circuit with dilp2, dilp3 and
dilp5, affects IIS-regulated traits in the adult and extends life-
span, pointing to the possibility that an IGFBP or a related pro-
tein could modulate mammalian aging.
Results
Eighty percent increase in Imp-L2 activates
transcription of 4E-BP
We ﬁrst determined if increasing the amount of Imp-L2 can
modulate IIS in adult ﬂies at a molecular level. Imp-L2 is
expressed in multiple tissues during development and in the
adult (Osterbur et al., 1988; Garbe et al., 1993; Honegger
et al., 2008), and so we chose to initially over-express it ubiqui-
tously. Since a strong ubiquitous over-expression of Imp-L2 is
lethal (Honegger et al., 2008), we used the genetically weaker
UAS-Imp-L2 transgene created by Honegger et al. (2008) and
drove its expression with a heatshockGAL4 (hsGAL4) driver at
25 C. This manipulation resulted in viable ﬂies and an 80%
increase in the levels of Imp-L2 mRNA in the adult female
(Fig. 1A), as detected by qPCR. To monitor protein levels, we
raised an antibody against recombinant IMP-L2 protein and
afﬁnity puriﬁed the serum. On western blots, we conﬁrmed the
previously observed apparent molecular weight of IMP-L2 as
30 kDa (Garbe et al., 1993), and detected 80% increase in
IMP-L2 protein in hsGAL4 > UAS-Imp-L2 ﬂies compared to the
pooled average of the two controls (Fig. 1B), an increase equiva-
lent to the mRNA increase. The details of mRNA and protein
quantiﬁcation methods are given in Experimental procedures.
IMP-L2 is predicted to be a secreted protein (Honegger et al.,
2008). Indeed, tagged IMP-L2 was efﬁciently secreted from S2
cells (data not shown). To conﬁrm this in vivo, we looked for the
native IMP-L2 in circulation. We could detect the protein in the
adult haemolymph, both using antibodies previously described
(data not shown) (Garbe et al., 1993) and the antibody we gen-
erated (Fig. 1C). hsGAL4 driven over-expression did not result in
substantial increases in circulating IMP-L2 (Fig. 1C), probably
because of low levels of induction at 25 C. To check that IMP-L2
protein could, in principle, be secreted from the transgene that
we used, we increased the level of induction of hsGAL4 by incu-
bating the ﬂies at 37 C for 2 h. This process resulted in a 8-
fold increase in the mRNA over the hsGAL4 control (data not
shown) and a marked increase in the haemolymph IMP-L2
(Fig. 1C), indicating that IMP-L2 protein from the transgene
could be correctly processed in our ﬂies.
To determine if this weak, ubiquitous over-expression of
Imp-L2 had an effect on molecular readouts of IIS status in the
adult, we looked at the activation of the transcription factor
thought to mediate the effects of IIS – dFOXO (Partridge &
Bruning, 2008). The overall phosphorylation status of dFOXO,
observed as slower migration on SDS-PAGE, reﬂects the activity
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Fig. 1 Over-expression of Imp-L2 with heatshockGAL4 driver. The ﬂies were reared at 25 C and harvested on day 7. (A) The transcript levels of Imp-L2 were
determined by qPCR, normalised to Act mRNA and the ratio in hsGAL4 set to one. Means and standard errors are shown with n = 6 for hsGAL4 > UAS-Imp-L2
and n = 7 for the two controls. The measurements for hsGAL4 > UAS-Imp-L2 were compared to those for hsGAL4 by t-test: P = 0.02, to UAS-Imp-L2: P = 0.05.
(B) The levels of IMP-L2 protein were determined in whole ﬂies by western blot, with actin as the loading control. The averages and standard errors of three
independent measurements of IMP-L2 protein normalised to actin are given below the images, with the average of pooled controls set to one. The levels in
hsGAL4 > UAS-Imp-L2 were signiﬁcantly different from the pooled controls (P = 0.04) or UAS-Imp-L2 (P = 0.01) but not from hsGAL4,b yt-test. (C) Levels of IMP-
L2 protein were determined in haemolymph by western blot. All ﬂies carried the hsGAL4 driver with or without UAS-Imp-L2 and were either kept at 25 Co r
placed at 37 C for 2 h prior to collection of haemolymph. Full genotypes of the ﬂies tested were: w
) ⁄ w
); hsGAL4 ⁄ +; + ⁄+, w
)⁄ w
);+⁄+; UAS-Imp-L2 ⁄ +, w
) ⁄w
);
hsGAL4 ⁄ +; UAS-Imp-L2 ⁄+. Note that in A and B, the differences between the two controls were not statistically signiﬁcant.
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138of IIS in cell culture (Puig et al., 2003). In vivo in the adult female,
strong down-regulation of IIS also reduces levels of phosphory-
lated dFOXO in whole-ﬂy extracts (Ikeya et al., 2009). Over-
expression of Imp-L2 did not result in an observable difference in
dFOXO phosphorylation (Fig. 2A), indicating that a strong
down-regulation of IIS did not occur in our ﬂies. Indeed, ablation
of the median neurosecretory cells (mNSC) that produce DILP2,
DILP3 and DILP5, a model of IIS reduction that increases adult
lifespan (Broughton et al., 2005), is also not enough to detecta-
bly alter whole-ﬂy dFOXO phosphorylation status (data not
shown). To detect more subtle changes in IIS, we examined the
mRNA levels of 4E-BP, a target of dFOXO (Junger et al., 2003),
which appears to mediate lifespan response to dietary restriction
(Zid et al., 2009), since low but prolonged activation of the tran-
scription factor could result in an observable accumulation of
the target message. Over-expression of Imp-L2 led to a signiﬁ-
cant increase (80%) in 4E-BP mRNA (Fig. 2B), consistent with
activation of dFOXO. The data indicated that a subtle down-
regulation of IIS occurs upon weak over-expression of Imp-L2 in
the adult.
Secreted IMP-L2 binds native DILP2 and DILP5
IMP-L2 has been shown to interact with Flag-tagged DILP2 in
insect cells (Arquier et al., 2008; Honegger et al., 2008). How-
ever, the increase in 4E-BP mRNA observed on over-expression
of Imp-L2 is not observed upon deletion of only dilp2, but
requires simultaneous deletion of dilp2, dilp3 and dilp5 (Gronke
et al., 2010). Therefore, it is likely that IMP-L2 can also bind DIL-
Ps other than DILP2, prompting us to seek evidence for a physi-
cal interaction. It was also important to establish whether IMP-
L2 interacts with the native version of DILP2, because modiﬁed
(Flag-tagged) DILP2 was used previously (Arquier et al., 2008;
Honegger et al., 2008).
We wanted to examine the ability of IMP-L2 to bind native i.e.
non-tagged and non-recombinant DILPs for two main reasons:
the physical structure, including C-chain excision, of DILPs has
not been characterised, precluding conﬁrmation of the correct
structure for a synthetic or recombinant DILP; and the presence
of a tag may signiﬁcantly alter the physical behaviour of DILPs
because of their small size. To achieve this, we used a far-
western blotting procedure, not requiring tagging or production
of synthetic or recombinant proteins. To focus on DILP2, DILP3
and DILP5, we used proteins extracted from ﬂy heads, where
these DILPs are produced (Broughton et al., 2005). We
expressed myc epitope-tagged IMP-L2 in S2 cells and, to insure
correct folding of the protein, we only used the secreted IMP-
L2-myc6, in the form of conditioned medium, to probe female
head proteins separated by non-reducing Tris–Tricine PAGE and
transferred to a nitrocellulose membrane. IMP-L2-myc6 binding
was then localised with an anti-myc antibody.
The far-western blotting revealed IMP-L2 binding to two pro-
teins of 8 and 12 kDa, and this speciﬁc binding was not
observed in the mock control using conditioned medium from
cells not expressing IMP-L2-myc6 (Fig. 3A,B). To identify the pro-
teins bound by IMP-L2-myc6 we used head protein extracts from
mutants deleted for each one of the three dilps produced in the
mNSC (Fig. 3A,B), and also probed the blots for DILP2 (not
shown), and for tubulin as a loading control (Fig. 3C). The
12 kDa band co-migrated with the band recognised by the anti-
DILP2 antibody (data not shown) and was absent in dilp2D⁄
dilp2D ﬂies (Fig. 3A,B), conﬁrming this is indeed DILP2. Hence,
secreted IMP-L2 can bind native DILP2. Note that a faint non-
speciﬁc band, migrating close to DILP2 and present in dilp2D⁄
dilp2D extracts, appears on the mock far-western blot (Fig. 3A)
and is probably attributable to non-speciﬁc binding of the
anti-myc antibody. The other speciﬁc band was absent in
dilp5D⁄dilp5D (Fig. 3A,B), indicating that IMP-L2 can also inter-
act with DILP5. The binding to DILP5 was weaker, and could be
more easily observed on a higher exposure of the far-western
blot (Fig. 3B), possibly because of lower levels of expression of
dilp5 compared to dilp2 (Broughton et al., 2005). Furthermore,
there appeared to be more DILP5 in dilp2D⁄dilp2D ﬂy heads
(Fig. 3A,B), and this ﬁnding is consistent with the compensatory
increase observed at the level of mRNA (Broughton et al., 2008;
Gronke et al., 2010).
Increased Imp-L2 feeds back onto dilp expression
As mentioned above, down-regulation or deletion of dilp2 res-
ults in up-regulation of dilp3 and dilp5 transcription (Broughton
et al., 2008; Gronke et al., 2010). Such feedback regulates in
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Fig. 2 Increase in Imp-L2 induces 4E-BP transcript. (A) The phosphorylation
of dFOXO in ﬂies over-expressing Imp-L2. The phosphorylation was monitored
as retardation on SDS-PAGE and dFOXO bands revealed by western blotting
with an anti-dFOXO antibody. In separate wild-type extracts, the slower
migrating band (dFOXOppp) was shown to disappear on treatment with calf
intestinal phosphatase (data not shown). (B) The transcript levels of 4E-BP
were determined by qPCR, normalised to Act mRNA and the ratio in hsGAL4
set to one. Means and standard errors are shown with n = 6 for
hsGAL4 > UAS-Imp-L2 and n = 7 for the two controls, P <1 0
)3 to either
control by t-test, while the differences between the two controls were not
signiﬁcant. Full genotypes of the ﬂies tested were: w
)⁄ w
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139part the transcription of dilp2, dilp3 and dilp5, and also encom-
passes Imp-L2 (Broughton et al., 2008; Gronke et al., 2010):
simultaneous deletion of dilp2, dilp3 and dilp5 results in a drop
in Imp-L2 transcript levels (Gronke et al., 2010), suggesting a
compensatory down-regulation of Imp-L2 in response to IIS
reduction. We wanted to examine if the inverse can also occur
i.e. if increased levels of Imp-L2 led to an elevation of dilp
expression levels. Indeed, driving Imp-L2 over-expression with
the hsGAL4 resulted in signiﬁcant increases (2-fold) in the
mRNA for dilp2, dilp3 and dilp5 (Fig. 4). Hence, dilp2, dilp3 and
dilp5, on one hand, and Imp-L2 on the other, reciprocally regu-
late each other’s expression, forming a circuit in which changes
in one are compensated by changes in the other.
Up-regulation of Imp-L2 increases lifespan
We next determined if weak, ubiquitous over-expression of
Imp-L2 was sufﬁcient to cause an observable phenotype. IIS
phenotypes tend to be more pronounced in female ﬂies (Clan-
cy et al., 2001; Giannakou et al., 2004; Hwangbo et al., 2004;
Broughton et al., 2005), so we used female ﬂies in our tests.
IIS regulates metabolism in the adult, and down-regulation of
IIS increases levels of stored lipids, whole body trehalose con-
tent and circulating sugars (Broughton et al., 2005, 2008).
Over-expression of Imp-L2 caused a signiﬁcant increase (21%)
in the levels of stored lipids, as measured by determining
whole-ﬂy triacylglycerol content (Fig. 5A). On the other hand,
while there was a trend towards an increase in the whole-ﬂy
trehalose content and the levels of circulating trehalose, glu-
cose or the combined sugars, these were not signiﬁcantly
altered (Fig. S1A,B). Furthermore, an increase in starvation
resistance was observed in only one of two trials performed
(Fig. S1C). Therefore, apart from an increase in stored lipids,
the effect of increasing Imp-L2 on metabolic traits was not
robust.
On the other hand, increasing Imp-L2 did clearly affects other
IIS-regulated traits. Over-expression of Imp-L2 resulted in slight,
but signiﬁcant, reduction (17%) in cumulative eggs laid by an
average female ﬂy per day over the ﬁrst 25 days of adult life
(Fig. 5B), showing that Imp-L2 could reduce fecundity. To exam-
ine their resistance to oxidative stress, we fed the ﬂies 5%
H2O2⁄sucrose food. The ﬂies over-expressing Imp-L2 survived
for signiﬁcantly longer (Fig. 5C), with a 23% increase in median
survival time, indicating that increasing Imp-L2 increases oxida-
tive stress resistance. Most importantly, over-expression of Imp-
L2 using the hsGAL4 driver signiﬁcantly extended the lifespan of
female ﬂies at 25 C (Fig. 5D), with median lifespan extended by
15%, while the maximum lifespan remained unchanged with
this driver. Note that, similar to over-expression of dfoxo
(Giannakou et al., 2004), hsGAL4 > UAS-Imp-L2 had no effect
on male lifespan (Fig. S2).
+
/
+
d
i
l
p
2
Δ
/
d
i
l
p
2
Δ
d
i
l
p
3
Δ
/
d
i
l
p
3
Δ
d
i
l
p
5
Δ
/
d
i
l
p
5
Δ
+
/
+
d
i
l
p
2
Δ
/
d
i
l
p
2
Δ
d
i
l
p
3
Δ
/
d
i
l
p
3
Δ
d
i
l
p
5
Δ
/
d
i
l
p
5
Δ
Mock IMP-L2-myc6
TUB
4
7
16
kDa
7
IMP-L2-myc6
(A)
(B) (C)
DILP2
DILP2
DILP5
DILP5
Fig. 3 IMP-L2 binds DILP2 and DILP5. (A) Far-
western blot was performed on head proteins
from ﬂies of the indicated genotypes using S2-cell
conditioned media containing either IMP-L2-myc6
(right-hand panel) or not (mock; left-hand panel)
and the binding of IMP-L2-myc6 visualised by an
anti-myc antibody. Bands corresponding to DILP2
and DILP5 are indicated. (B) Higher exposure of
the far-western shown above in A. (C) Tubulin
used as loading control. Note that in all the panels
the lanes shown align with the genotypes
indicated in A. Full genotypes of the ﬂies tested
were: w
) ⁄ w
);+⁄+; + ⁄+, w
)⁄ w
);+⁄+;
dilp2D ⁄ dilp2D, w
)⁄ w
);+⁄+; dilp3D ⁄ dilp3D,
w
) ⁄w
);+⁄ +; dilp5D ⁄ dilp5D.
0
1
2
3
4
5
dilp2
dilp3
dilp5
hsGAL4 UAS-Imp-L2 hsGAL4>
UAS-Imp-L2
d
i
l
p
/
A
c
t
 
m
R
N
A
Fig. 4 Increase in Imp-L2 results in increased dilp2, dilp3 and dilp5
transcription. The levels of dilp2, dilp3 and dilp5 transcripts were determined
by qPCR in whole ﬂy RNA, normalised to Act mRNA and the average ratio of
the two control genotypes set to one for each transcript. Means and standard
errors are shown with n = 4 for all measurements except for dilp5 in UAS-
Imp-L2 where n = 3. Two-way ANOVA showed that the effect of genotype was
signiﬁcant: P <1 0
)4, where hsGAL4 > UAS-Imp-L2 was different to both
controls by t-test while the differences between the two controls were not
signiﬁcant, and there was no signiﬁcant interaction between genotype and
transcript. Full genotypes of the ﬂies tested were: w
)⁄ w
); hsGAL4 ⁄+; + ⁄+,
w
) ⁄w
);+⁄ +; UAS-Imp-L2 ⁄+, w
)⁄ w
); hsGAL4 ⁄+; UAS-Imp-L2 ⁄ +.
IGFBP and lifespan, N. Alic et al.
ª 2011 The Authors
Aging Cell ª 2011 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland
140Adult-onset over-expression of Imp-L2 can extend
lifespan
The hsGAL4 driver is expressed in both the pre-adult and adult
periods, and the lifespan-extension upon over-expression of
Imp-L2 achieved with this driver could thus be attributed to a
developmental effect. To examine adult-onset over-expression,
we used the inducible Actin GeneSwitch (ActGS) driver. ActGS
drives ubiquitous transgene expression but only in the presence
of the RU486 steroid drug (Ford et al., 2007). Addition of
RU486 to food had no effect on lifespan of ActGS or UAS-Imp-
L2 controls (Fig. S3), while in ActGS > UAS-Imp-L2 adult female
ﬂies it almost doubled the period where no deaths were
observed and resulted in a 20% increase in median lifespan, as
well as a smaller increase in maximal lifespan (Fig. 6A), demon-
strating that effect of Imp-L2 on lifespan can be separated from
its developmental effects.
Interestingly, while ActGS > UAS-Imp-L2 female ﬂies showed
an almost 3-fold increase in Imp-L2 mRNA upon RU486 feeding
(Fig. 6B), the levels of IMP-L2 protein were only 80% increased
(Fig. 6C). This apparent block to translation is indicative of trans-
lational control that appears exerted on both the native Imp-L2
and the transgene we used (Honegger et al., 2008). The reason
why the ActGS driver had a more substantial effect on lifespan
than hsGAL4 may be because, in the case of the latter, the levels
of IMP-L2 were increased in circulation (Fig. 6C). Adult-speciﬁc
ubiquitous induction of Imp-L2 also resulted in signiﬁcantly
increased levels of dilp2 and 4E-BP mRNA (Fig. 6B), as well as a
decrease in fecundity (Fig. S4A) and an increase in H2O2 resis-
tance (Fig. S4B). However, the increase in 4E-BP observed here
(30%, Fig. 6B) was lower than with hsGAL4 (80%, Fig. 2B),
indicating that prolonged IIS down-regulation or down-regula-
tion during development may be required for a pronounced
effect on 4E-BP expression, and that the magnitude of lifespan
extension is not proportional to the levels of 4E-BP mRNA.
Tissue-speciﬁc over-expression of Imp-L2 can extend
lifespan
Since IMP-L2 is a secreted protein, we were interested in deter-
mining if tissue-restricted over-expression can extend lifespan.
In both the larvae and the adult, IMP-L2 is produced in distinct
cells of both brain hemispheres (Honegger et al., 2008). How-
ever, driving UAS-Imp-L2 expression with the pan-neuronal elav-
GAL4 driver (Luo et al., 1994) did not extend lifespan (Fig. S5).
IMP-L2 is also produced in the corpora cardiaca, part of the ring
gland (Honegger et al., 2008), but driving UAS-Imp-L2 with the
corpora cardiaca-speciﬁc akhGAL4 driver (Kim & Rulifson, 2004)
also failed to extend lifespan (Fig. S5). IMP-L2 is also expressed
in the mNSCs, together with DILP2, DILP3 and DILP5 (Honegger
et al., 2008). Driving UAS-Imp-L2 expression with the dilp2-
GAL4 driver, expressed only in the mNSCs starting from the
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)⁄ w
); hsGAL4 ⁄+; + ⁄+, w
)⁄ w
);+⁄+; UAS-Imp-L2 ⁄ +, w
) ⁄w
); hsGAL4 ⁄ +; UAS-Imp-L2 ⁄+. Note
that in all panels the differences between the two controls were not statistically signiﬁcant.
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141third-instar larval stage (Broughton et al., 2005), signiﬁcantly
extended lifespan of female ﬂies (Fig. 7A), prolonging the med-
ian survival time by 10%. The magnitude of the extension was
similar to the one observed with hsGAL4, suggesting that the
majority of the effect on lifespan of ubiquitous over-expression
can be recapitulated by increased expression at the site of DILP2,
DILP3 and DILP5 production.
IMP-L2 is also expressed in the ﬂy gut and fat body (Honegger
et al., 2008). The S1106 driver activates expression in these tis-
sues upon addition of RU486 steroid drug to food (Poirier et al.,
2008). Adult-onset induction of S1106 > UAS-Imp-L2 also sig-
niﬁcantly extended female ﬂy lifespan (Fig. 7A), while addition
of RU486 to food of S1106 or UAS-Imp-L2 controls had no effect
(Fig. S3). Hence, IMP-L2 production in the gut⁄fat body can also
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Fig. 7 Tissue-restricted over-expression of Imp-L2 increases lifespan. (A) Lifespans of female ﬂies over-expressing Imp-L2 in the mNSC (dilp2GAL4 > UAS-Imp-L2,
W
dah n = 142, med = 71 days, max = 77 days; w
1118 n = 141, med = 65 days, max = 72 days) and the two genetic controls (dilp2GAL4, W
dah n = 149,
med = 66 days, max = 74 days; w
1118 n = 140, med = 59 days, max = 67 days; UAS-Imp-L2, W
dah n = 142, med = 66 days, max = 74 days; w
1118 n = 142,
med = 59 days, max = 67 days; top two panels) or female ﬂies in which over-expression of Imp-L2 in the gut and fat body by the S1106 driver was induced at day
3 of adulthood by RU486 (S1106 > UAS-Imp-L2 + RU486, W
dah n = 143. med = 69 days, max = 77 days; w
1118 n = 144, med = 65 days, max = 74 days) or the
uninduced controls (S1106 > UAS-Imp-L2)RU486, W
dah n = 143, med = 62, max = 74; w
1118 n = 150, med = 63 days, max = 70 days; lower two panels), in
outbred W
dah (two panels on the left) and the inbred w
1118 (two panels on the right). The survival of dilp2GAL4 > UAS-Imp-L2 was signiﬁcantly different from the
two controls in both backgrounds by Log-rank test (P <1 0
)4). Log-rank test also showed the survival of S1106 > UAS-Imp-L2 signiﬁcantly altered by addition of
RU486, with P <1 0
)6 for W
dah, P = 0.003 for w
1118. In all cases, the maximal lifespan was extended upon Imp-L2 over-expression (P < 0.05 by Log-rank test on
the ﬁnal 10% survivors). (B) IMP-L2 was measured in the haemolymph of dilp2GAL4 > UAS-Imp-L2 female ﬂies and the two genetic controls, or in S1106 > UAS-
Imp-L2 female ﬂies fed or not with RU486, by western blotting. (C) IMP-L2 was visualised with immunoﬂuorescence in the guts of S1106 > UAS-Imp-L2 female
ﬂies fed or not with RU486. IMP-L2 is indicated in red, DAPI-stained nuclei in blue. Note the red ﬂuorescence of the gut contents. The numbers next to the images
give the mean and standard error of relative ﬂuorescence intensity per unit area of gut as quantiﬁed, after background subtraction, from at least three animals
(P = 0.01 by t-test). (D) IMP-L2 was visualised with immunoﬂuorescence in the mNSC of wandering third-instar dilp2GAL4 > UAS-Imp-L2 larvae or the two
genetic controls. mNSC were identiﬁed with an anti-DILP5 antibody (green), IMP-L2 is indicated in red, DAPI in blue. The numbers next to the images give the
mean and standard error of relative ﬂuorescence intensity per mNSC quantiﬁed, after background subtraction, and averaged over at least three cells from four
animals (n =4 ,t-test dilp2GAL4 > UAS-Imp-L2 to dilp2GAL4 P = 0.04, to UAS-Imp-L2 P = 0.001). (E) Levels of dilp2 mRNA relative to Act mRNA were
determined in the ﬂies of the indicated genotypes ⁄treatments, with n = 6 and the levels set to 1 in relevant controls. The levels in S1106 > UAS-Imp-L2 were
signiﬁcantly altered by addition of RU486 (t-test: P = 0.05). Full genotypes of the ﬂies used: w
) ⁄w
);+⁄ +; dilp2GAL4 ⁄+, w
)⁄ w
);+⁄+; UAS-Imp-L2 ⁄ +, w
) ⁄w
);
+ ⁄ +; dilp2GAL4 ⁄UAS-Imp-L2, w
) ⁄w
); S1106 ⁄ +; UAS-Imp-L2 ⁄k. Note that in all cases the differences between dilp2GAL4 and UAS-Imp-L2 controls were not
statistically signiﬁcant.
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142contribute to longevity. With both the dilp2GAL4 and S1106
drivers, the maximum lifespan was also extended (Fig. 7A), con-
ﬁrming that Imp-L2 over-expression can extend maximum life-
span. In both cases, the enhanced longevity was observed in
two different ﬂy strains, the outbred W
dah and the inbred w
1118
(Fig. 7A), indicating that it is robust to genetic background.
Similar to the situation in hsGAL4 > UAS-Imp-L2, the level
of circulating IMP-L2 was not substantially increased in
S1106 > UAS-Imp-L2 ﬂies fed RU486-containing food, or in
dilp2GAL4 > UAS-ImpL2 compared to controls (Fig. 7B). On the
other hand, there were detectable increases in IMP-L2 protein in
the gut of S1106 > UAS-Imp-L2 ﬂies in presence of RU486
0
0.2
0.4
0.6
0.8
1
0 1 02 03 04 05 06 07 08 09 01 0 0
0
0.2
0.4
0.6
0.8
1
0 1 02 03 04 05 06 07 08 09 01 0 0
0
0.2
0.4
0.6
0.8
1
0 1 02 03 04 05 06 07 08 09 0 1 0 0
0
0.2
0.4
0.6
0.8
1
0 1 02 03 04 05 06 07 08 09 01 0 0
– RU486
+ RU486
dilp2GAL4
UAS-Imp-L2
dilp2GAL4>
UAS-Imp-L2
S1106>UAS-Imp-L2 
S
u
r
v
i
v
a
l
 
(
%
)
S
u
r
v
i
v
a
l
 
(
%
)
Time (day) Time (day)
Wdah W1118 (A)
(B)
Cut cells
Gut
contents
Gut cells
Gut
contents
DAPI IMP-L2
+ RU486
– RU486
1
.
0
 
±
 
0
.
2
2
.
1
 
±
 
0
.
2
F
l
u
o
r
e
s
c
e
n
c
e
/
a
r
e
a
(C)
S
1
1
0
6
>
U
A
S
-
I
m
p
-
L
2
 
Haemolymph
–
 
R
U
4
8
6
+
 
R
U
4
8
6
S1106>UAS-Imp-L2 
IMP-L2
d
i
l
p
2
G
A
L
4
U
A
S
-
I
m
p
-
L
2
d
i
l
p
2
G
A
L
4
>
U
A
S
-
I
m
p
-
L
2
d
i
l
p
2
G
A
L
4
U
A
S
-
I
m
p
-
L
2
d
i
l
p
2
G
A
L
4
>
U
A
S
-
I
m
p
-
L
2 DAPI IMP-L2 DILP5
1
.
9
 
±
 
0
.
1
0
.
7
 
±
 
0
.
2
1
.
3
 
±
 
0
.
2
F
l
u
o
r
e
s
c
e
n
c
e
/
m
N
S
C
(D)
0
0.5
1
1.5
2
–
 
R
U
4
8
6
+
 
R
U
4
8
6
S1106>
UAS-Imp-L2 
d
i
l
p
2
G
A
L
4
U
A
S
-
I
m
p
-
L
2
d
i
l
p
2
G
A
L
4
>
U
A
S
-
I
m
p
-
L
2
d
i
l
p
2
/
A
c
t
 
m
R
N
A
(E)
IGFBP and lifespan, N. Alic et al.
ª 2011 The Authors
Aging Cell ª 2011 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland
143(Fig. 7C; no signiﬁcant increase was detectable in the fat body,
Fig. S6), or in the mNSC of the third-instar dilp2GAL4 > UAS-
Imp-L2 larvae compared to controls (Fig. 7D), conﬁrming the
induction of the transgene. Note that certain other cells in the
brain normally express much higher levels of IMP-L2 than those
attained in the mNSC with dilp2GAL4 (Fig. S7), so that the con-
tribution from mNSC to the total pool of IMP-L2, even in the
dilp2GAL4 > UAS-Imp-L2 ﬂies, is likely to be negligible, and not
proportionate to its effect on lifespan. Hence, the site of expres-
sion, rather than the levels of IMP-L2, is relevant.
Tissue-speciﬁc induction of Imp-L2 appeared to selectively tar-
get lifespan and not other IIS regulated traits since, with both
dilp2GAL4 and S1106 drivers, there was no effect on fecundity,
stress resistance or 4E-BP expression (Fig. S8). Intriguingly, the
levels of dilp2 mRNA were only increased when Imp-L2 was
induced in the gut⁄fat body, and not when it was induced in the
mNSC (Fig. 7E), indicating that the feedback to dilp expression
may occur via the former tissue(s).
Discussion
In this study we determined the function of Imp-L2 in adult-
hood, and found that its over-expression caused phenotypic
changes consistent with negative regulation of IIS. Importantly,
we found that this genetic manipulation of IIS could extend life-
span, which is not the case for all IIS-targeted interventions
(Clancy et al., 2001; Tatar et al., 2001; Hwangbo et al., 2004;
Selman et al., 2008; Ikeya et al., 2009). It will be interesting to
determine if this longevity-enhancing role of Imp-L2 can be per-
formed by an IGFBP or an IGFBP-rP, such as IGFBP7, in mam-
mals. IGFBP7 has been characterised as a tumour suppressor,
acting as a secreted senescence⁄apoptosis factor (Wajapeyee
et al., 2008). Establishing and examining the role of IGFBP7 in
lifespan may shed light on the relationship between cellular
senescence, cancer and whole organism aging in mammals, an
important emerging ﬁeld of study (Campisi & Yaswen, 2009).
Our data are consistent with IMP-L2 regulating IIS by seques-
tering the DILP ligands. In this respect, it is important that our
binding assay was performed with native DILP proteins, reveal-
ing for the ﬁrst time that IMP-L2 can bind native DILP5 as well as
native DILP2. Interestingly, we did not observe binding to any
other ﬂy head proteins, despite the expression of DILP3 and
DILP4 in the head (Ikeya et al., 2002; Broughton et al., 2005;
Gronke et al., 2010), implying that IMP-L2 can discriminate
amongst different DILPs. However, this lack of observable bind-
ing may have also resulted from differential levels of expression
of native DILPs e.g. from the very low levels of expression of
dilp3 in the mNSC (Broughton et al., 2005). IMP-L2 can proba-
bly also bind DILPs other than DILP2 and DILP5, because strong
over-expression of the protein is lethal (Honegger et al., 2008),
but simultaneous deletion of dilp2, dilp3 and dilp5 is not
(Gronke et al., 2010). The dilp2D⁄dilp2D dilp3D⁄dilp3D
dilp5D⁄dilp5D dilp6D⁄dilp6D quadruple mutant is lethal (Gro-
nke et al., 2010), indicating that IMP-L2 may bind DILP6. Alter-
natively, IMP-L2 may also have DILP-independent effects, in a
similar way that some IGFBPs appear to have IGF-independent
functions (Mohan & Baylink, 2002).
Interestingly, sequence analysis indicates that DILPs are
cleaved and processed like insulin (Gronke et al., 2010), how-
ever, no study to date has physically observed these processed
forms of DILPs. While we have previously observed DILP2 on a
western blot (Broughton et al., 2008), this is the ﬁrst time that
the native DILP5 has been observed on an SDS-PAGE. For both
of these DILPs, the apparent molecular weight is too large for
the processed DILPs (predicted molecular weight of DILP2 and
DILP5 processed like insulin is 6 kDa) and is closer to the
predicted molecular weight of the pro-peptide or an uncleaved
IGF-like peptide (13 and 10 kDa for DILP2 and DILP5 respec-
tively). IMP-L2¢s ability to bind these uncleaved forms is consis-
tent with its binding to human pro-insulin, IGF-I and IGF-II, as
well as insulin (Sloth Andersen et al., 2000), also indicating that
these uncleaved forms of DILPs may be functional in the ﬂy.
Removal of dilp2, dilp3 and dilp5 results in down-regulation
of Imp-L2 transcription (Gronke et al., 2010), and we show here
that, reciprocally, up-regulation of Imp-L2 results in up-regula-
tion of the mRNAs for all three dilps. This compensatory feed-
back loop is, in both cases, not sufﬁcient to completely correct
the disturbance of the ﬂy IIS status since both genetic manipula-
tions result in phenotypes consistent with down-regulation of IIS
including lifespan extension. Interestingly we ﬁnd that over-
expression of Imp-L2 in the mNSC does not result in increased
dilp2 mRNA, indicating that this feedback does not occur via
an⁄a autocrine⁄paracrine mechanism. Rather, the feedback
occurs via effector(s) produced in the gut⁄fat body, since up-
regulation of Imp-L2 in these tissues resulted in increased dilp2
transcript levels. Hence, peripheral tissues, such as the fat body,
are not only in charge of regulating DILP release from the mNSC
in response to nutritional changes, as has been observed in
larvae (Geminard et al., 2009), but are also main regulators of
dilp synthesis in response to changes to adult IIS status.
Our study indicates that an agent present in circulation has an
effect on lifespan; a ﬁnding that may have important therapeu-
tic applications. Indeed, the genetic manipulation that led to
increased IMP-L2 levels in the haemolymph (ActGS > UAS-Imp-
L2 + RU486) was the one that resulted in the most substantial
increase to longevity. Interestingly, in other cases where we
could observe an extension of lifespan, we did not observe a
substantial increase in the levels of circulating IMP-L2. It is possi-
ble that IMP-L2 was secreted but then retained in a target tissue,
so that no net increase was observed in circulation. Alterna-
tively, IMP-L2 may have predominantly acted in an⁄a auto-
crine⁄paracrine manner. In either case, IMP-L2 could have been
retained in speciﬁc tissue(s) based on its interactions with com-
ponents of extracellular matrix or cell surface proteins, as is
known for IGFPBs (Hwa et al., 1999; Mohan & Baylink, 2002). In
the case of dilp2GAL4 > UAS-Imp-L2, the over-expression of
IMP-L2 might have been very efﬁcient in sequestering DILPs at
the site of their production. In the case of S1106 driven over-
expression, the gut may be the most relevant tissue since it is
here that we could observe a substantial increase in IMP-L2.
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144Increased activity of dFOXO using the same S1106 driver is sufﬁ-
cient to extend lifespan (Giannakou et al., 2004), and the gut
may be the relevant tissue in this case as well. Interestingly, out
of all the IIS-regulated adult traits, lifespan was most sensitive to
increased Imp-L2, since no other phenotypes examined were
responsive to tissue-speciﬁc Imp-L2 induction.
Experimental procedures
Fly stocks and husbandry, phenotypic tests
UAS-Imp-L2 this is the genetically weaker transgene generated
by Honegger et al. (2008), heatshockGAL4 (Bloomington Stock
Center), dilp2GAL4 (Broughton et al., 2005), S1106 (Giannakou
et al., 2004), ActGS (Ford et al., 2007), dilp2D⁄dilp2D, dilp3D⁄
dilp3D and dilp5D⁄dilp5D (Gronke et al., 2010) were back-
crossed at least six times into the outbred Dahomey background
carrying the w
1118 mutation (W
dah) (Giannakou et al., 2004),
which had been cured of the Wolbachia infection; or the inbred
w
1118background,whichisWolbachiafree.NotethattheActGS
line used (255B) is thought to have multiple insertions of the dri-
ver (Ford et al., 2007), however, after more than six backcrosses
we did not observe any segregation of different dye colours. All
experiments were performed at 25 C, 12-hour light⁄dark cycle,
and controlled humidity, on female ﬂies in W
dah background,
unless otherwise noted. Flies were reared at standard density on
SYA food (5% sucrose, 10% yeast, 1.5% agar), female ﬂies
sorted on day 3 and kept ten per vial. Where required, induction
by RU486 was performed as described previously (Giannakou
et al., 2004). For starvation, ﬂies were kept on 1% agar, and for
H2O2 treatment on food containing 1% agar, 5% sucrose, 5%
H2O2, starting on day 5. For RNA or protein extraction the ﬂies
were frozen in liquid nitrogen on day 7. Lifespan experiments,
whole-ﬂy trehalose, circulating sugar (Parrou & Francois, 1997;
Broughton et al., 2008) or whole-ﬂy lipid (Gronke et al., 2005)
quantiﬁcations wereperformed asdescribed.
Antibody production, western blots and
immunoﬂuorescence
cDNA coding for IMP-L2 without the signal peptide was ampli-
ﬁed from W
dah cDNA using the primers: CACCAGAGCCGTG-
GACCTGGTAGACG and TTAGTCTTCCTCATTAAGTACGGGA-
TAC, cloned into pENTR⁄D-TOPO vector (Invitrogen, Paisley,
UK), sequenced and transferred into pDEST17 vector (Invitro-
gen) adding a His6 tag. The protein was expressed in BL21(DES3)
E. coli, recovered in the insoluble fraction and puriﬁed under
denaturing conditions on Ni-NTA agarose (Quagen, Crawley,
UK), followed by preparative SDS-PAGE. Anti-IMP-L2 antibody
was raised in rabbits by Eurogentec (Eurogentec, Fawley, UK),
and afﬁnity puriﬁed against rIMP-L2. Fly protein extractions and
western blots were performed as described (Giannakou et al.,
2007; Broughton et al., 2008). Afﬁnity puriﬁed anti-Imp-L2 was
used at 1:2000 dilution. For quantiﬁcation, the blots were devel-
oped with ECL, images captured with LAS-1000 cooled CCD
(Fujiﬁlm; Fujiﬁlm UK Ltd, Bedfordshire, UK) and band intensities
determined with ImageJ (freeware from Research Services
Branch, National Institute of Mental Health, Bethesda, Mary-
land, USA). The quantity of IMP-L2 was expressed relative to
ACT, with this ratio set to one in the control geno-
types⁄untreated ﬂies. Haemolymph was extracted from 7-day
old female ﬂies as described (Broughton et al., 2008) and 1 lL
used for western blots. Images presented were taken on ﬁlm.
For immunoﬂuorescence, ﬂies were dissected in ice-cold PBS
and stained as described (Broughton et al., 2010) with the afﬁn-
ity puriﬁed anti-IMP-L2 antibody at 1:1000 dillution and Texas-
Red conjugated secondary antibody, and co-stained where
required with rat anti-DILP5 and AlexaFluor488 conjugated sec-
ondary antibody as described (Broughton et al., 2010). Images
were captured on Zeiss LSM 700 (Carl Zeiss Ltd, Hertfordshire,
UK), and quantiﬁed using ImageJ.
Far-western blotting
The last two exons of Imp-L2, which include the signal peptide,
were ampliﬁed from W
dah genomic DNA with the primers: CAC-
CATGAATTTACATGTGTGCGCCTTAG and GTCTTCCTCATT-
AAGTACGGGATAC, cloned in to pENTR⁄D-TOPO vector,
sequenced and transferred into pTWM (giving UASt-Imp-L2-
myc6). S2 cells were cultured in serum-free medium (Invitrogen)
and co-transfected using Cellfectin (Invitrogen) with plasmids
encoding either Act5C-GAL4, UASp-GFP and UASt-Imp-L2-myc6
(producing IMP-L2-myc6)o rAct5C-GAL4 and UASp-GFP (mock
control), and the conditioned media harvested after 3 days.
Hundred micrograms of ﬂy-head proteins were separated on
non-reducing Tris–Tricine PAGE and transferred to nitrocellulose
membranes as described (Broughton et al., 2008). The mem-
branes were blocked in PBST (PBS + 0.2% Tween-20) with 5%
BSA, probedover-night with a 1in 10 dilution ofthe conditioned
media in the same buffer at 4 C and IMP-L2-myc6 binding visual-
ised with an anti-myc (Sigma, Dorset, UK) western blot.
qPCR
RNA extraction, cDNA synthesis and qPCR were performed as
described (Broughton et al., 2008), except for dilp qPCR which
was performed on 7900HT Fast Real-Time PCR System using
Fast Syber Green Master Mix (Applied Biosystems). The Act,
dilp2, dilp3 and dilp5 primers have been described (Broughton
et al., 2008). The following primers were used for Imp-L2:
CCTCATTAAGTACGGGATAC and CTTCTGATCTCCGAGATCA-
AG; for 4E-BP: CACTCCTGGAGGCACCA and GAGTTCCCCT-
CAGCAAGCAA. The amount of the relevant mRNA was
expressed relative to Act mRNA and this ratio set to one in the
control genotypes⁄untreated ﬂies.
Statistical analysis
Statistical analysis was performed either in JMP (SAS, Cary, NC,
USA) or Excel. Details are given in ﬁgure legends.
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Additional supporting information may be found in the online
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Fig. S1 Whole body trehalose content, circulating sugars and
starvation resistance in hsGAL4 > UAS-Imp-L2 ﬂies.
Fig. S2 Life spans of hsGAL4 > UAS-Imp-L2 male ﬂies.
Fig. S3 Lack of effect of RU486 addition to ActGS, UAS-Imp-L2
or S1106 controls.
Fig. S4 Reduced fecundity and increased H2O2 resistance upon
induction of Imp-L2 with the ActGS driver.
Fig. S5 Lifespans of elavGAL4 > UAS-Imp-L2 and akhGAL4 >
UAS-Imp-L2 ﬂies.
Fig. S6 IMP-L2 produced in the fat body of induced S1106 >
UAS-Imp-L2 adult female ﬂies.
Fig. S7 IMP-L2 distribution in larval brains.
Fig. S8 Lack of effect on fecundity, H2O2 resistance and 4E-BP
expression upon induction of Imp-L2 with the dilp2GAL4 or the
S1106 driver.
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